Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485484 · ClinicalTrials.gov registry record
Development and Validation of a NIRS-based Sinusitis Screening
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 161
- Enrollment target
NCT01485484: Completed study, sponsored by University of California, Irvine.
NCT01485484 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01485484 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
The research at University of California Irvine, Beckman laser institute and Praxis Biosciences Incorporation, develope near-infrared trans-illumination methods. The optical imaging tool that can determine acute sinusitis and the response to treatment therapy.
Primary Outcome
Assessment of sinusitis
Interventions
- DEVICE Optic imaging use near-infrared trans-illumination methods
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2011-07-28 |
| Est. Completion | 2015-07-07 |
What the finished NCT01485484 record still lists
NCT01485484 is an observational study that tracks outcomes without assigning an intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Optic imaging use near-infrared trans-illumination methods is the first listed.
NCT01485484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01485484 about?
NCT01485484 is a clinical study titled "Development and Validation of a NIRS-based Sinusitis Screening". The research at University of California Irvine, Beckman laser institute and Praxis Biosciences Incorporation, develope near-infrared trans-illumination methods. The optical imaging tool that can determine acute sinusitis and the response to treatment therapy.
What is the current status of trial NCT01485484?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2011-07-28. Estimated completion is 2015-07-07.
What interventions are being tested in trial NCT01485484?
The interventions under investigation include: Optic imaging use near-infrared trans-illumination methods (DEVICE).
Who is sponsoring clinical trial NCT01485484?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI